Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response.

ABSTRACT:

SUBMITTER: Munoz-Vendrell A 

PROVIDER: S-EPMC12764079 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature